Multiply Labs builds advanced robotic systems for manufacturing precision medicines at scale. Its technology applies robotics, AI, and automation to the life science industry, specifically targeting cell therapy manufacturing and personalized pharmaceuticals.
The company's primary product consists of modular robotic clusters featuring multiple collaborative robot arms that work in parallel. These systems produce personalized pharmaceutical capsules and cell therapies. Multiply Labs reports that its approach achieves a 74% reduction in manufacturing costs compared to traditional methods.
